Zhifang R. Liu

Shandong Provincial Key Laboratory Of Applied Technology For Protein And Peptide Drugs, State Key Laboratory Of Macromolecular Drugs And Large Scale Preparation
Liaocheng, 252000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R.

Development of Telmisartan Platinum(IV) Complexes for Antimetastatic Therapy: Targeting EMT and Tumor Immunity through Suppressing AT1R.

Journal: Journal of medicinal chemistry

Published: July 04, 2026

Novel captopril-valproic acid platinum(IV) hybrids with potent antiproliferative and antimetastatic activities targeting fibrosis and DNA-repair.

Novel captopril-valproic acid platinum(IV) hybrids with potent antiproliferative and antimetastatic activities targeting fibrosis and DNA-repair.

Journal: European journal of medicinal chemistry

Published: May 06, 2026

D-band center modulation-enabled enhancement of adsorption and electrochemical detection for niclosamide by α-MnO2-supported dry gel-derived Fe3O4@N-doped porous carbon.

D-band center modulation-enabled enhancement of adsorption and electrochemical detection for niclosamide by α-MnO2-supported dry gel-derived Fe3O4@N-doped porous carbon.

Journal: Journal of hazardous materials

Published: October 12, 2025

NAT10 promotes cisplatin resistance and immune escape by increasing the expression of DUSP1 and PD-L1 in gastric cancer.

NAT10 promotes cisplatin resistance and immune escape by increasing the expression of DUSP1 and PD-L1 in gastric cancer.

Journal: Cell death discovery

Published: October 11, 2025

Development of Ciprofibrate Platinum(IV) Nanodrugs as Antimetastatic Agents with COFs as Carriers.

Development of Ciprofibrate Platinum(IV) Nanodrugs as Antimetastatic Agents with COFs as Carriers.

Journal: Journal of medicinal chemistry

Published: September 17, 2025

METTL3-mediated m6A modification of circCDYL promotes gastric cancer progression by acting as miR-378a-5p sponge to regulate USP13 expression.

METTL3-mediated m6A modification of circCDYL promotes gastric cancer progression by acting as miR-378a-5p sponge to regulate USP13 expression.

Journal: Cellular signalling

Published: July 16, 2025

Grapefruit Extracellular-Vesicle-Derived Nanodrug Loading Three-Functional Platinum(IV) Conjugates with Enhanced Targeting and TME Modulating Properties.

Grapefruit Extracellular-Vesicle-Derived Nanodrug Loading Three-Functional Platinum(IV) Conjugates with Enhanced Targeting and TME Modulating Properties.

Journal: Journal of medicinal chemistry

Published: May 26, 2025

Circular RNA hsa_circ_0002669 is down-regulated by Helicobacter pylori and inhibits the gastric cancer progression via miR-223-3p/ARID1A axis.

Circular RNA hsa_circ_0002669 is down-regulated by Helicobacter pylori and inhibits the gastric cancer progression via miR-223-3p/ARID1A axis.

Journal: American journal of cancer research

Published: April 28, 2025

Autophagy-targeted Pt(IV) agents: a new horizon in antitumor drug development.

Autophagy-targeted Pt(IV) agents: a new horizon in antitumor drug development.

Journal: Dalton transactions (Cambridge, England : 2003)

Published: January 13, 2025

Ursodeoxycholic Acid Platinum(IV) Conjugates as Antiproliferative and Antimetastatic Agents: Remodel the Tumor Microenvironment through Suppressing JAK2/STAT3 Signaling.

Ursodeoxycholic Acid Platinum(IV) Conjugates as Antiproliferative and Antimetastatic Agents: Remodel the Tumor Microenvironment through Suppressing JAK2/STAT3 Signaling.

Journal: Journal of medicinal chemistry

Published: September 18, 2024

Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial-Mesenchymal Transition Suppression, and Immune Activation Properties.

Transferrin-Modified Carprofen Platinum(IV) Nanoparticles as Antimetastasis Agents with Tumor Targeting, Inflammation Inhibition, Epithelial-Mesenchymal Transition Suppression, and Immune Activation Properties.

Journal: Journal of medicinal chemistry

Published: September 05, 2024

Cetirizine platinum(IV) complexes with antihistamine properties inhibit tumor metastasis by suppressing angiogenesis and boosting immunity.

Cetirizine platinum(IV) complexes with antihistamine properties inhibit tumor metastasis by suppressing angiogenesis and boosting immunity.

Journal: Journal of inorganic biochemistry

Published: September 02, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026